Article

Report: DME more prevalent in African-Americans

African-Americans seem to be at higher risk for diabetic macular edema (DME), according to research by the Keck School of Medicine at the University of Southern California (USC).

 

Los Angeles-African-Americans seem to be at higher risk for diabetic macular edema (DME), according to research by the Keck School of Medicine at the University of Southern California (USC).

The research-published recently in the Journal of the American Medical Association (JAMA) Ophthalmology-found a higher burden of diabetes-related vision loss among certain ethnic populations because of problems with access to care, explained corresponding author Rohit Varma, MD, MPH, director of the USC Eye Institute, professor and chairman of ophthalmology at the Keck School of Medicine of USC.

More in this issue: Valeant’s takeover attempt of Allergan continues to heat up

“We were surprised that our research showed that African-Americans have the highest rates of DME, when Hispanics tend to have the highest prevalence of diabetes,” Dr. Varma said. “There is not enough vision screening for DME among diabetics, yet there are much better therapies available that are covered by insurance.

“We hope that our research will help those in the position to influence policy to get a better handle on costs and where the need for treatment is the greatest,” he continued.

 

Dr. Varma’s team conducted the study by using the National Health and Nutrition Examination Study (NHANES) database.

The next target for research in this area, Dr. Varma said, will be examining barriers to access to eye care among African Americans.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.